Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$67.53 0.80 (1.2%) as of 4:30 Thu 9/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 26.31(B)
Last Volume: 3,294,635 Avg Vol: 2,072,018
52 Week Range: $64 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:
    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  520
Guru Rank Value     : 3.6
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 4,915 71,783 301,616 583,537
Total Sell Value $371,314 $9,377,154 $39,059,786 $70,857,495
Total People Sold 5 8 14 16
Total Sell Transactions 7 19 46 88
End Date 2024-06-27 2024-03-26 2023-09-26 2022-09-26

   
Records found: 2316
  Page 40 of 93  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Gregg Terrance H Executive Chairman   •       •      –    2016-11-09 4 D $62.17 $135,042 D/D (2,172) 444,944     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2016-10-24 4 AS $81.95 $844,065 D/D (10,300) 120,709     -
   Roper Jess SVP, CFO   •       –      –    2016-10-24 4 AS $80.75 $199,544 D/D (2,471) 74,215     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2016-10-24 4 AS $81.12 $258,110 I/I (3,182) 25,461     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2016-10-19 4 AS $82.31 $411,303 D/D (4,997) 106,345     -
   Sayer Kevin R President & CEO   •       •      –    2016-10-14 4 AS $81.87 $573,101 D/D (7,000) 299,891     -
   Lister John General Manager, EMEA   •       –      –    2016-10-10 4 AS $84.41 $300,508 D/D (3,560) 74,015     -
   Gregg Terrance H Executive Chairman   •       •      –    2016-10-10 4 D $83.35 $180,619 D/D (2,167) 447,116     -
   Valdes Jorge A CTO   •       –      –    2016-10-10 4 AS $84.42 $928,579 D/D (11,000) 72,334     -
   Valdes Jorge A CTO   •       –      –    2016-10-10 4 OE $7.63 $83,930 D/D 11,000 83,334     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2016-10-05 4 AS $82.55 $412,750 D/D (5,000) 111,342     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2016-09-23 4 AS $94.00 $968,196 D/D (10,300) 131,009     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2016-09-23 4 AS $93.97 $299,000 I/I (3,182) 28,643     -
   Roper Jess SVP, CFO   •       –      –    2016-09-22 4 AS $93.99 $232,155 D/D (2,470) 76,686     -
   Balo Andrew K EVP, Clinical and Regulatory   •       –      –    2016-09-21 4 AS $92.87 $464,366 D/D (5,000) 116,342     -
   Sayer Kevin R President & CEO   •       •      –    2016-09-14 4 AS $91.79 $642,527 D/D (7,000) 306,891     -
   Moy Jeffrey SVP, Operations   •       –      –    2016-09-13 4 GD $0.00 $0 I/I 290 50,556     -
   Kahn Barbara Director   –       •      –    2016-09-12 4 S $92.90 $464,512 I/I (5,000) 24,304     -
   Skyler Jay S Director   –       •      –    2016-09-12 4 S $93.00 $930,000 I/I (10,000) 0     -
   Valdes Jorge A CTO   •       –      –    2016-09-12 4 AS $92.06 $650,965 I/I (7,071) 3,499     -
   Skyler Jay S Director   –       •      –    2016-09-09 4 S $94.07 $2,351,788 I/I (25,000) 17,246     -
   Moy Jeffrey SVP, Operations   •       –      –    2016-09-09 4 D $93.72 $749,876 I/I (8,001) 50,846     -
   Moy Jeffrey SVP, Operations   •       –      –    2016-09-09 4 A $65.80 $1,236,924 I/I 14,999 58,847     -
   Moy Jeffrey SVP, Operations   •       –      –    2016-09-09 4 D $95.80 $1,436,904 D/D (14,999) 61,334     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2016-09-09 4 D $93.72 $966,561 D/D (10,313) 141,309     -
  2316 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 40 of 93
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us